UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

~~FORM~~Form 8-K

~~CURRENT~~Current ~~REPORT~~Report

Pursuant Toto Section 13 or 15(d)

Ofof the Securities ~~and~~ Exchange Act Ofof 1934

~~October~~Date of Report (Date of earliest event reported): November 295, 2013

Date of Report (Date of earliest event reported)

ACTAVIS, INC.

(Exact name of registrant as specified in its charter)

Nevada	001-13305	95-3872914
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification Number)
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
Morris Corporate Center III 400 Interpace Parkway Parsippany, New Jersey		07054
(Address of principal executive offices)		(Zip Code)

Morris Corporate Center III

400 Interpace Parkway

Parsippany, New Jersey

07054

(Address of Principal Executive Offices)

(862) 261-7000

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 25.02 ~~Results~~Departure of ~~Operations~~Directors ~~and~~or ~~Financial~~Certain ~~Condition~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~October~~November 295, 2013, ~~Actavis~~the ~~plc issued~~Compensation aCommittee ~~press~~of ~~release~~the ~~reporting~~Board of Directors (the ~~financial~~“Compensation ~~results~~Committee”) of Actavis plc (the “Parent”), of which Actavis, Inc. (the “Company”), is a wholly-owned subsidiary, approved the grant of ~~Actavis~~retention ~~plc~~bonuses payable in cash to the Parent’s Named Executive Officers (who were designated as Named Executive Officers in the Company’s definitive proxy statement on Schedule 14A, ~~for~~filed with the ~~third~~Securities ~~quarter~~and ~~ended~~Exchange ~~September~~Commission on March 3029, 2013), and ~~providing~~certain amembers ~~forecast~~ of ~~certain~~its ~~estimated~~management ~~financial~~team (collectively, the “Officers”). The ~~metrics~~Compensation ~~for~~Committee ~~2013~~determined ~~and~~that ~~2014.~~it Ais ~~copy~~in the best interests of the ~~press~~Parent ~~release~~to ~~reporting~~grant retention bonus awards (the ~~financial~~“Awards”), ~~results~~in ofamounts ~~the~~ranging ~~Company~~from is$200,000 ~~attached~~to $5,000,000, in order to ~~this~~ensure ~~report~~the asOfficers’ ~~Exhibit~~continued ~~99.1~~retention and service ~~incorporated~~to ~~herein~~the ~~by reference~~Parent. The total retention bonus amounts payable to each of the Parent’s Named Executive Officers are set forth in the table below next to such Officer’s name:

In its press release, Actavis plc discloses non-GAAP financial measures (as defined in Regulation G promulgated by the U. S. Securities and Exchange Commission) that exclude certain significant charges or credits that are important to an understanding of the Company’s ongoing operations. Actavis plc believes that its inclusion of non-GAAP financial measures provides useful supplementary information to and facilitates analysis by investors in evaluating the Company’s performance and trends. The determination of significant charges or credits may not be comparable to similar measures used by other companies and may vary from period to period. Actavis plc uses both GAAP financial measures and the disclosed non-GAAP financial measures internally to evaluate and manage the Company’s operations and to better understand its business. These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.


Paul Bisaro	President & CEO	$	5,000,000
Siggi Olafsson	President, Actavis Pharma	$	4,000,000
Robert Stewart	President, Global Operations	$	3,000,000
David Buchen	Chief Legal Officer - Global and Secretary	$	1,000,000
Todd Joyce	Chief Financial Officer - Global	$	1,000,000

~~Non-GAAP~~The ~~net~~Awards ~~income~~provide ~~and~~that ~~non~~the Officer must be employed as a regular full-~~GAAP~~time ~~earnings~~employee ~~per~~by ~~share~~the ~~are~~Parent ~~supplemental~~or ~~measures~~one of its ~~our~~subsidiaries ~~performance~~on ~~that~~the ~~are~~applicable ~~not~~date ~~required~~of byAward vesting, except as otherwise described below. Awards of $1,000,000 or ~~presented~~less ~~in accordance~~will ~~with~~vest 100% on January 1, ~~GAAP~~2015 and will be payable, less appropriate withholding of taxes, no later than March 1, 2015. WeAwards ~~define~~in ~~non-GAAP~~excess ~~net~~of ~~income~~$1,000,000 aswill ~~net~~vest ~~income~~50% ~~adjusted~~on ~~for~~January 1, ~~amortization~~2015 and 50% on January 1, ~~acquisition~~2016, and ~~licensing~~will ~~charges~~in each case be payable, ~~expenses~~less ~~associated~~appropriate ~~with~~withholding ~~our~~of ~~operational~~taxes, ~~excellence/global~~within ~~supply~~60 ~~chain~~days ~~initiative~~of ~~(including~~the ~~accelerated~~date ~~depreciation~~such vesting occurs. In the ~~charges~~event ~~associated~~an ~~therewith),~~Officer’s ~~legal~~employment ~~settlements~~is ~~and~~terminated ~~certain~~by ~~special~~the ~~charges~~Parent ~~that~~without ~~are~~cause ~~otherwise~~or ~~included~~by inthe ~~GAAP~~Officer ~~net~~for ~~income~~good reason, ~~including~~in ~~loss~~each ~~(gain) on~~case ~~asset~~as ~~sales/impairment~~defined in the relevant Award agreements, ~~loss~~or ~~(gain) on~~is ~~security~~terminated ~~sales~~for ~~and~~death ~~impairment~~or disability, ~~loss~~any onunpaid ~~debt repurchases~~portion ~~and~~of ~~income~~any ~~taxes.~~outstanding Award ~~Non-GAAP~~granted ~~earnings~~to ~~per~~the ~~share~~Officer ~~refers~~will tobecome ~~non-GAAP~~payable ~~net~~within ~~income~~30 ~~divided~~days byfollowing the ~~number~~date of ~~diluted~~such ~~shares outstanding~~termination.

The information in this report (including the exhibits) is furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

d. Exhibits:

99.1 Press Release of Actavis, plc entitled “Actavis Net Revenue Increases 57% to $2.01 Billion in Third Quarter 2013; Non-GAAP EPS Increases 55% to $2.09” dated October 29, 2013.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: October 29, 2013		ACTAVIS, INC.
	By:	/s/ R. Todd Joyce
		R. Todd Joyce
		Chief Financial Officer - Global

Dated: November 8, 2013

~~EXHIBIT~~ACTAVIS, ~~INDEX~~INC. By: /s/ David A. Buchen Name: David A. Buchen Title: Chief Legal Officer – Global and Secretary

ExhibitNo.		Description
99.1		Press Release of Actavis plc entitled “Actavis Net Revenue Increases 57% to $2.01 Billion in Third Quarter 2013; Non-GAAP EPS Increases 55% to $2.09” dated October 29, 2013.

Filing Compare · Allergan Finance LLC